![Bettina Cockroft](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bettina Cockroft
Director/Board Member at
ANNEXON, INC.
Net worth: 5 $ as of 2026-05-30
Profile
Bettina M.
Cockroft is currently an Independent Director at Annexon, Inc. since 2022 and an Independent Director at CNS Pharmaceuticals, Inc. since 2023.
Formerly, served as Chief Medical Officer & Senior Vice President at Sangamo Therapeutics, Inc. from 2019 to 2023, Vice President-Clinical Research at Cytokinetics, Inc. from 2017 to 2019, and Chief Medical Officer at Auris Medical AG from 2013 to 2016.
Education includes a doctorate from the University of Genoa and an MBA from MIT Sloan School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-26 | 1 ( 0% ) | 5 $ | 2026-05-30 | |
ANNEXON, INC. -.--% | 2026-03-30 | 0 ( -.--% ) | - $ | 2026-05-30 |
Bettina Cockroft active positions
| Companies | Position | Start |
|---|---|---|
| ANNEXON, INC. | Director/Board Member | 2022-01-19 |
| CNS PHARMACEUTICALS, INC. | Director/Board Member | 2023-05-07 |
Former positions of Bettina Cockroft
| Companies | Position | End |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2023-05-15 |
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | 2019-08-31 |
Auris Medical AG
 Auris Medical AG Medical SpecialtiesHealth Technology Manufactures electronic devices for ear disorders | Chief Tech/Sci/R&D Officer | 2016-08-31 |
Training of Bettina Cockroft
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Annexon, Inc.
 Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
University of Genoa
 University of Genoa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Auris Medical AG
Auris Medical AG Medical SpecialtiesHealth Technology Manufactures electronic devices for ear disorders | Health Technology |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CNS Pharmaceuticals, Inc.
 CNS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical drugs | Health Technology |
- Stock Market
- Insiders
- Bettina Cockroft
